カテゴリー： QYResearch, 世界

世界の性感染症薬市場 2019年

【英語タイトル】Global Sexually Transmitted Diseases Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X14940）・商品コード：DATA909X14940
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、性感染症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、抗ウイルス剤/抗レトロウイルス剤、抗生物質、ワクチンに、用途別には、病院、病院、その他にセグメント区分し、性感染症薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・性感染症薬の世界市場概要
・性感染症薬の製造コスト構成分析
・性感染症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・性感染症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・性感染症薬のセグメント分析（種類別）
（抗ウイルス剤/抗レトロウイルス剤、抗生物質、ワクチン）
・性感染症薬のセグメント分析（用途別）
（病院、病院、その他）
・性感染症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Pfizer INC、Merck & Co., Inc.、Gilead Sciences、Hoffmann La Roche、Bayer Healthcare、Eli Lilly、Bristol-Myers Squibb Co. AbbVie, Inc.、Johnson & Johnson、GlaxoSmithKline Plc、）
・性感染症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Sexually Transmitted Diseases Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Sexually Transmitted Diseases Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sexually Transmitted Diseases Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Sexually Transmitted Diseases Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Sexually Transmitted Diseases Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer INC
Merck & Co., Inc.
Gilead Sciences
Hoffmann La Roche
Bayer Healthcare
Eli Lilly
Bristol-Myers Squibb Co. AbbVie, Inc.
Johnson & Johnson
GlaxoSmithKline Plc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Antiviral / Antiretrovirals
Antibiotics
Vaccines

Segment by Application
Hospital
Cinic
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Sexually Transmitted Diseases Drug
1.1 Definition of Sexually Transmitted Diseases Drug
1.2 Sexually Transmitted Diseases Drug Segment by Type
1.2.1 Global Sexually Transmitted Diseases Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Antiviral / Antiretrovirals
1.2.3 Antibiotics
1.2.4 Vaccines
1.3 Sexually Transmitted Diseases Drug Segment by Applications
1.3.1 Global Sexually Transmitted Diseases Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Cinic
1.3.4 Other
1.4 Global Sexually Transmitted Diseases Drug Overall Market
1.4.1 Global Sexually Transmitted Diseases Drug Revenue (2014-2025)
1.4.2 Global Sexually Transmitted Diseases Drug Production (2014-2025)
1.4.3 North America Sexually Transmitted Diseases Drug Status and Prospect (2014-2025)
1.4.4 Europe Sexually Transmitted Diseases Drug Status and Prospect (2014-2025)
1.4.5 China Sexually Transmitted Diseases Drug Status and Prospect (2014-2025)
1.4.6 Japan Sexually Transmitted Diseases Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Sexually Transmitted Diseases Drug Status and Prospect (2014-2025)
1.4.8 India Sexually Transmitted Diseases Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Sexually Transmitted Diseases Drug
2.3 Manufacturing Process Analysis of Sexually Transmitted Diseases Drug
2.4 Industry Chain Structure of Sexually Transmitted Diseases Drug

3 Development and Manufacturing Plants Analysis of Sexually Transmitted Diseases Drug
3.1 Capacity and Commercial Production Date
3.2 Global Sexually Transmitted Diseases Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Sexually Transmitted Diseases Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Sexually Transmitted Diseases Drug Production and Capacity Analysis
4.2 Sexually Transmitted Diseases Drug Revenue Analysis
4.3 Sexually Transmitted Diseases Drug Price Analysis
4.4 Market Concentration Degree

5 Sexually Transmitted Diseases Drug Regional Market Analysis
5.1 Sexually Transmitted Diseases Drug Production by Regions
5.1.1 Global Sexually Transmitted Diseases Drug Production by Regions
5.1.2 Global Sexually Transmitted Diseases Drug Revenue by Regions
5.2 Sexually Transmitted Diseases Drug Consumption by Regions
5.3 North America Sexually Transmitted Diseases Drug Market Analysis
5.3.1 North America Sexually Transmitted Diseases Drug Production
5.3.2 North America Sexually Transmitted Diseases Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Sexually Transmitted Diseases Drug Import and Export
5.4 Europe Sexually Transmitted Diseases Drug Market Analysis
5.4.1 Europe Sexually Transmitted Diseases Drug Production
5.4.2 Europe Sexually Transmitted Diseases Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Sexually Transmitted Diseases Drug Import and Export
5.5 China Sexually Transmitted Diseases Drug Market Analysis
5.5.1 China Sexually Transmitted Diseases Drug Production
5.5.2 China Sexually Transmitted Diseases Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Sexually Transmitted Diseases Drug Import and Export
5.6 Japan Sexually Transmitted Diseases Drug Market Analysis
5.6.1 Japan Sexually Transmitted Diseases Drug Production
5.6.2 Japan Sexually Transmitted Diseases Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Sexually Transmitted Diseases Drug Import and Export
5.7 Southeast Asia Sexually Transmitted Diseases Drug Market Analysis
5.7.1 Southeast Asia Sexually Transmitted Diseases Drug Production
5.7.2 Southeast Asia Sexually Transmitted Diseases Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Sexually Transmitted Diseases Drug Import and Export
5.8 India Sexually Transmitted Diseases Drug Market Analysis
5.8.1 India Sexually Transmitted Diseases Drug Production
5.8.2 India Sexually Transmitted Diseases Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Sexually Transmitted Diseases Drug Import and Export

6 Sexually Transmitted Diseases Drug Segment Market Analysis (by Type)
6.1 Global Sexually Transmitted Diseases Drug Production by Type
6.2 Global Sexually Transmitted Diseases Drug Revenue by Type
6.3 Sexually Transmitted Diseases Drug Price by Type

7 Sexually Transmitted Diseases Drug Segment Market Analysis (by Application)
7.1 Global Sexually Transmitted Diseases Drug Consumption by Application
7.2 Global Sexually Transmitted Diseases Drug Consumption Market Share by Application (2014-2019)

8 Sexually Transmitted Diseases Drug Major Manufacturers Analysis
8.1 Pfizer INC
8.1.1 Pfizer INC Sexually Transmitted Diseases Drug Production Sites and Area Served
8.1.2 Pfizer INC Product Introduction, Application and Specification
8.1.3 Pfizer INC Sexually Transmitted Diseases Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Merck & Co., Inc.
8.2.1 Merck & Co., Inc. Sexually Transmitted Diseases Drug Production Sites and Area Served
8.2.2 Merck & Co., Inc. Product Introduction, Application and Specification
8.2.3 Merck & Co., Inc. Sexually Transmitted Diseases Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Gilead Sciences
8.3.1 Gilead Sciences Sexually Transmitted Diseases Drug Production Sites and Area Served
8.3.2 Gilead Sciences Product Introduction, Application and Specification
8.3.3 Gilead Sciences Sexually Transmitted Diseases Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Hoffmann La Roche
8.4.1 Hoffmann La Roche Sexually Transmitted Diseases Drug Production Sites and Area Served
8.4.2 Hoffmann La Roche Product Introduction, Application and Specification
8.4.3 Hoffmann La Roche Sexually Transmitted Diseases Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bayer Healthcare
8.5.1 Bayer Healthcare Sexually Transmitted Diseases Drug Production Sites and Area Served
8.5.2 Bayer Healthcare Product Introduction, Application and Specification
8.5.3 Bayer Healthcare Sexually Transmitted Diseases Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eli Lilly
8.6.1 Eli Lilly Sexually Transmitted Diseases Drug Production Sites and Area Served
8.6.2 Eli Lilly Product Introduction, Application and Specification
8.6.3 Eli Lilly Sexually Transmitted Diseases Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Bristol-Myers Squibb Co. AbbVie, Inc.
8.7.1 Bristol-Myers Squibb Co. AbbVie, Inc. Sexually Transmitted Diseases Drug Production Sites and Area Served
8.7.2 Bristol-Myers Squibb Co. AbbVie, Inc. Product Introduction, Application and Specification
8.7.3 Bristol-Myers Squibb Co. AbbVie, Inc. Sexually Transmitted Diseases Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Johnson & Johnson
8.8.1 Johnson & Johnson Sexually Transmitted Diseases Drug Production Sites and Area Served
8.8.2 Johnson & Johnson Product Introduction, Application and Specification
8.8.3 Johnson & Johnson Sexually Transmitted Diseases Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 GlaxoSmithKline Plc
8.9.1 GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Production Sites and Area Served
8.9.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.9.3 GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Sexually Transmitted Diseases Drug Market
9.1 Global Sexually Transmitted Diseases Drug Market Trend Analysis
9.1.1 Global Sexually Transmitted Diseases Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Sexually Transmitted Diseases Drug Regional Market Trend
9.2.1 North America Sexually Transmitted Diseases Drug Forecast 2019-2025
9.2.2 Europe Sexually Transmitted Diseases Drug Forecast 2019-2025
9.2.3 China Sexually Transmitted Diseases Drug Forecast 2019-2025
9.2.4 Japan Sexually Transmitted Diseases Drug Forecast 2019-2025
9.2.5 Southeast Asia Sexually Transmitted Diseases Drug Forecast 2019-2025
9.2.6 India Sexually Transmitted Diseases Drug Forecast 2019-2025
9.3 Sexually Transmitted Diseases Drug Market Trend (Product Type)
9.4 Sexually Transmitted Diseases Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Sexually Transmitted Diseases Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Sexually Transmitted Diseases Drug
Table Global Sexually Transmitted Diseases Drug Production (MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Sexually Transmitted Diseases Drug Production Market Share by Types in 2018
Figure Antiviral / Antiretrovirals Product Picture
Figure Antibiotics Product Picture
Figure Vaccines Product Picture
Table Global Sexually Transmitted Diseases Drug Consumption (MT) Comparison by Applications (2014-2025)
Figure Global Sexually Transmitted Diseases Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Cinic
Figure Other
Figure Global Sexually Transmitted Diseases Drug Revenue (Million USD) (2014-2025)
Figure Global Sexually Transmitted Diseases Drug Production (MT) (2014-2025)
Figure North America Sexually Transmitted Diseases Drug Market Size (Million USD) (2014-2025)
Figure Europe Sexually Transmitted Diseases Drug Market Size (Million USD) (2014-2025)
Figure China Sexually Transmitted Diseases Drug Market Size (Million USD) (2014-2025)
Figure Japan Sexually Transmitted Diseases Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Sexually Transmitted Diseases Drug Market Size (Million USD) (2014-2025)
Figure India Sexually Transmitted Diseases Drug Market Size (Million USD) (2014-2025)
Table Sexually Transmitted Diseases Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Sexually Transmitted Diseases Drug in 2018
Figure Manufacturing Process Analysis of Sexually Transmitted Diseases Drug
Figure Industry Chain Structure of Sexually Transmitted Diseases Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Sexually Transmitted Diseases Drug Manufacturing Plants Distribution
Table Sexually Transmitted Diseases Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Sexually Transmitted Diseases Drug Capacity (MT) of Major Manufacturers (2014-2019)
Table Sexually Transmitted Diseases Drug Production (MT) of Major Manufacturers (2014-2019)
Table Sexually Transmitted Diseases Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Sexually Transmitted Diseases Drug Production Share by Manufacturers in 2018
Table Sexually Transmitted Diseases Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Sexually Transmitted Diseases Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Sexually Transmitted Diseases Drug Revenue Share by Manufacturers in 2018
Table Sexually Transmitted Diseases Drug Average Price (USD/Kg) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Sexually Transmitted Diseases Drug Production by Regions 2014-2019 (MT)
Table Global Sexually Transmitted Diseases Drug Production Market Share by Regions 2014-2019
Figure Global Sexually Transmitted Diseases Drug Production Market Share by Regions in 2018
Table Global Sexually Transmitted Diseases Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Sexually Transmitted Diseases Drug Revenue Market Share by Regions 2014-2019
Figure Global Sexually Transmitted Diseases Drug Revenue Market Share by Regions in 2018
Table Global Sexually Transmitted Diseases Drug Consumption by Regions 2014-2019 (MT)
Table Global Sexually Transmitted Diseases Drug Consumption Market Share by Regions 2014-2019
Figure North America Sexually Transmitted Diseases Drug Production Growth Rate 2014-2019 (MT)
Figure North America Sexually Transmitted Diseases Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Sexually Transmitted Diseases Drug Production, Consumption Import and Export (MT)
Figure Europe Sexually Transmitted Diseases Drug Production Growth Rate 2014-2019 (MT)
Figure Europe Sexually Transmitted Diseases Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Sexually Transmitted Diseases Drug Production, Consumption Import and Export (MT)
Figure China Sexually Transmitted Diseases Drug Production Growth Rate 2014-2019 (MT)
Figure China Sexually Transmitted Diseases Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Sexually Transmitted Diseases Drug Production, Consumption Import and Export (MT)
Figure Japan Sexually Transmitted Diseases Drug Production Growth Rate 2014-2019 (MT)
Figure Japan Sexually Transmitted Diseases Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Sexually Transmitted Diseases Drug Production, Consumption Import and Export (MT)
Figure Southeast Asia Sexually Transmitted Diseases Drug Production Growth Rate 2014-2019 (MT)
Figure Southeast Asia Sexually Transmitted Diseases Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Sexually Transmitted Diseases Drug Production, Consumption Import and Export (MT)
Figure India Sexually Transmitted Diseases Drug Production Growth Rate 2014-2019 (MT)
Figure India Sexually Transmitted Diseases Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Sexually Transmitted Diseases Drug Production, Consumption Import and Export (MT)
Figure Global Consumption Sexually Transmitted Diseases Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Sexually Transmitted Diseases Drug Market Share by Application (2014-2019)
Table Pfizer INC Sexually Transmitted Diseases Drug Production Sites and Area Served
Table Pfizer INC Sexually Transmitted Diseases Drug Product Introduction, Application and Specification
Table Pfizer INC Sexually Transmitted Diseases Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer INC Sexually Transmitted Diseases Drug Production Growth Rate (2014-2019)
Table Pfizer INC Sexually Transmitted Diseases Drug Production Market Share (2014-2019)
Figure Pfizer INC Sexually Transmitted Diseases Drug Revenue Market Share (2014-2019)
Table Pfizer INC Sexually Transmitted Diseases Drug Main Business and Markets Served
Table Merck & Co., Inc. Sexually Transmitted Diseases Drug Production Sites and Area Served
Table Merck & Co., Inc. Sexually Transmitted Diseases Drug Product Introduction, Application and Specification
Table Merck & Co., Inc. Sexually Transmitted Diseases Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Merck & Co., Inc. Sexually Transmitted Diseases Drug Production Growth Rate (2014-2019)
Table Merck & Co., Inc. Sexually Transmitted Diseases Drug Production Market Share (2014-2019)
Figure Merck & Co., Inc. Sexually Transmitted Diseases Drug Revenue Market Share (2014-2019)
Table Merck & Co., Inc. Sexually Transmitted Diseases Drug Main Business and Markets Served
Table Gilead Sciences Sexually Transmitted Diseases Drug Production Sites and Area Served
Table Gilead Sciences Sexually Transmitted Diseases Drug Product Introduction, Application and Specification
Table Gilead Sciences Sexually Transmitted Diseases Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Gilead Sciences Sexually Transmitted Diseases Drug Production Growth Rate (2014-2019)
Table Gilead Sciences Sexually Transmitted Diseases Drug Production Market Share (2014-2019)
Figure Gilead Sciences Sexually Transmitted Diseases Drug Revenue Market Share (2014-2019)
Table Gilead Sciences Sexually Transmitted Diseases Drug Main Business and Markets Served
Table Hoffmann La Roche Sexually Transmitted Diseases Drug Production Sites and Area Served
Table Hoffmann La Roche Sexually Transmitted Diseases Drug Product Introduction, Application and Specification
Table Hoffmann La Roche Sexually Transmitted Diseases Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Hoffmann La Roche Sexually Transmitted Diseases Drug Production Growth Rate (2014-2019)
Table Hoffmann La Roche Sexually Transmitted Diseases Drug Production Market Share (2014-2019)
Figure Hoffmann La Roche Sexually Transmitted Diseases Drug Revenue Market Share (2014-2019)
Table Hoffmann La Roche Sexually Transmitted Diseases Drug Main Business and Markets Served
Table Bayer Healthcare Sexually Transmitted Diseases Drug Production Sites and Area Served
Table Bayer Healthcare Sexually Transmitted Diseases Drug Product Introduction, Application and Specification
Table Bayer Healthcare Sexually Transmitted Diseases Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Bayer Healthcare Sexually Transmitted Diseases Drug Production Growth Rate (2014-2019)
Table Bayer Healthcare Sexually Transmitted Diseases Drug Production Market Share (2014-2019)
Figure Bayer Healthcare Sexually Transmitted Diseases Drug Revenue Market Share (2014-2019)
Table Bayer Healthcare Sexually Transmitted Diseases Drug Main Business and Markets Served
Table Eli Lilly Sexually Transmitted Diseases Drug Production Sites and Area Served
Table Eli Lilly Sexually Transmitted Diseases Drug Product Introduction, Application and Specification
Table Eli Lilly Sexually Transmitted Diseases Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Eli Lilly Sexually Transmitted Diseases Drug Production Growth Rate (2014-2019)
Table Eli Lilly Sexually Transmitted Diseases Drug Production Market Share (2014-2019)
Figure Eli Lilly Sexually Transmitted Diseases Drug Revenue Market Share (2014-2019)
Table Eli Lilly Sexually Transmitted Diseases Drug Main Business and Markets Served
Table Bristol-Myers Squibb Co. AbbVie, Inc. Sexually Transmitted Diseases Drug Production Sites and Area Served
Table Bristol-Myers Squibb Co. AbbVie, Inc. Sexually Transmitted Diseases Drug Product Introduction, Application and Specification
Table Bristol-Myers Squibb Co. AbbVie, Inc. Sexually Transmitted Diseases Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Co. AbbVie, Inc. Sexually Transmitted Diseases Drug Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Co. AbbVie, Inc. Sexually Transmitted Diseases Drug Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Co. AbbVie, Inc. Sexually Transmitted Diseases Drug Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Co. AbbVie, Inc. Sexually Transmitted Diseases Drug Main Business and Markets Served
Table Johnson & Johnson Sexually Transmitted Diseases Drug Production Sites and Area Served
Table Johnson & Johnson Sexually Transmitted Diseases Drug Product Introduction, Application and Specification
Table Johnson & Johnson Sexually Transmitted Diseases Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Johnson & Johnson Sexually Transmitted Diseases Drug Production Growth Rate (2014-2019)
Table Johnson & Johnson Sexually Transmitted Diseases Drug Production Market Share (2014-2019)
Figure Johnson & Johnson Sexually Transmitted Diseases Drug Revenue Market Share (2014-2019)
Table Johnson & Johnson Sexually Transmitted Diseases Drug Main Business and Markets Served
Table GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Production Sites and Area Served
Table GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Main Business and Markets Served
Figure Global Sexually Transmitted Diseases Drug Production (MT) Growth Rate Forecast 2019-2025
Figure Global Sexually Transmitted Diseases Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Sexually Transmitted Diseases Drug Sales Price (USD/Kg) Forecast 2019-2025
Figure North America Sexually Transmitted Diseases Drug Production Growth Rate Forecast 2019-2025 (MT)
Figure North America Sexually Transmitted Diseases Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Sexually Transmitted Diseases Drug Production Growth Rate Forecast 2019-2025 (MT)
Figure Europe Sexually Transmitted Diseases Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Sexually Transmitted Diseases Drug Production Growth Rate Forecast 2019-2025 (MT)
Figure China Sexually Transmitted Diseases Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Sexually Transmitted Diseases Drug Production Growth Rate Forecast 2019-2025 (MT)
Figure Japan Sexually Transmitted Diseases Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Sexually Transmitted Diseases Drug Production Growth Rate Forecast 2019-2025 (MT)
Figure Southeast Asia Sexually Transmitted Diseases Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Sexually Transmitted Diseases Drug Production Growth Rate Forecast 2019-2025 (MT)
Figure India Sexually Transmitted Diseases Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (MT) of Sexually Transmitted Diseases Drug by Type (2019-2025)
Table Global Consumption (MT) of Sexually Transmitted Diseases Drug by Application (2019-2025)
Table Sexually Transmitted Diseases Drug Distributors List
Table Sexually Transmitted Diseases Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Pfizer INC、Merck & Co., Inc.、Gilead Sciences、Hoffmann La Roche、Bayer Healthcare、Eli Lilly、Bristol-Myers Squibb Co. AbbVie, Inc.、Johnson & Johnson、GlaxoSmithKline Plc、

★調査レポート[世界の性感染症薬市場 2019年] (コード：DATA909X14940)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の性感染症薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の性感染症（STD）検査機器市場 2019年
    DATA909X14939 / QYResearch / 2019年11月20日 / ※本調査レポートは、性感染症（STD）検査機器の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、サーマルサイクラー、ラテラルフローリーダー、フローサイトメーター、示差光散乱機、その他に、用途別には、臨床検査、ポイントオブケア検査にセグメント区分し、性感染症（STD）検査機器の世界市場を分析しました。 ・エグゼクティブ・サマリー ・性感染症（STD）検査機器の世界市場概要 ・性感染症（STD）検査機器の製造コスト構成分析 ・性感染症（STD）検査機器の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・性感染症（STD）検査機器の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・性感染症（STD）検査機器のセグメント分析（種類別） （サーマルサイクラー、ラテラルフローリーダー、フローサイトメーター、示差光散乱機、その他）...The global Sexually Transmitted Diseases (STDs) Testing Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Sexually Transmitted Diseases (STDs) Testing Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sexually Transmitted Diseases (STDs) Testing Devices market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Sexually Transmitted Diseases (STDs) Testing Devices in North America, Europe, China,...
  • 性感染症（STD）検査の世界市場：規模・現状・予測2019-2025
    DATA909X18961 / QYResearch / 2019年11月25日 / ※当調査レポートでは、性感染症（STD）検査の世界市場について調査・分析し、性感染症（STD）検査の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（実験室試験装置、POC試験装置）、用途別（病院、研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の性感染症（STD）検査市場動向 ・主要企業別マーケットシェア ・性感染症（STD）検査の種類別市場規模2014-2019 （実験室試験装置、POC試験装置） ・性感染症（STD）検査の用途別市場規模2014-2019 （病院、研究所、クリニック、その他） ・性感染症（STD）検査の北米市場：主要企業・種類別/用途別市場規模 ・性感染症（STD）検査のヨーロッパ市場：主要企業・種類別/用途別市場規模...Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD).The need for tests that eliminate certain patient and provider barriers, which hamper routine screening, is rising. In line with this, vendors of the global STD testing market are providing rapid POC testing kits. Moreover, the preference for self-testing for HIV is growing rapidly across the world. Most of the HIV test kits provide accurate results within 5-20 minutes. Also, molecular diagnostics used for STD testing are also undergoing rapid advances. In 2018, the global Sexually Transmitted Disease (STD) Testing market size...
  • 世界の呼吸器疾患用診断検査市場 2019年
    DATA909X14325 / QYResearch / 2019年11月20日 / ※本調査レポートは、呼吸器疾患用診断検査の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、画像検査、呼吸測定、血液ガス検査、その他に、用途別には、病院、診療所、臨床検査室、その他にセグメント区分し、呼吸器疾患用診断検査の世界市場を分析しました。 ・エグゼクティブ・サマリー ・呼吸器疾患用診断検査の世界市場概要 ・呼吸器疾患用診断検査の製造コスト構成分析 ・呼吸器疾患用診断検査の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・呼吸器疾患用診断検査の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・呼吸器疾患用診断検査のセグメント分析（種類別） （画像検査、呼吸測定、血液ガス検査、その他）...The global Respiratory Diseases Diagnostic Testing market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Respiratory Diseases Diagnostic Testing volume and value at global level, regional level and company level. From a global perspective, this report represents overall Respiratory Diseases Diagnostic Testing market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Respiratory Diseases Diagnostic Testing in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の顧みられない熱帯病（NTD）診断市場 2019年
    DATA909X11918 / QYResearch / 2019年11月20日 / ※本調査レポートは、顧みられない熱帯病（NTD）診断の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、従来法、分子/現代法に、用途別には、臨床検査室、病院/クリニック、在宅医療にセグメント区分し、顧みられない熱帯病（NTD）診断の世界市場を分析しました。 ・エグゼクティブ・サマリー ・顧みられない熱帯病（NTD）診断の世界市場概要 ・顧みられない熱帯病（NTD）診断の製造コスト構成分析 ・顧みられない熱帯病（NTD）診断の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・顧みられない熱帯病（NTD）診断の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・顧みられない熱帯病（NTD）診断のセグメント分析（種類別） （従来法、分子/現代法）...The global Neglected Tropical Diseases Diagnosis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neglected Tropical Diseases Diagnosis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neglected Tropical Diseases Diagnosis market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Neglected Tropical Diseases Diagnosis in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の筋肉内薬物送達機器市場 2019年
    DATA909X10009 / QYResearch / 2019年11月20日 / ※本調査レポートは、筋肉内薬物送達機器の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、分子構造、ポリマー、ゲル、その他に、用途別には、感染症、腫瘍学、自己免疫疾患にセグメント区分し、筋肉内薬物送達機器の世界市場を分析しました。 ・エグゼクティブ・サマリー ・筋肉内薬物送達機器の世界市場概要 ・筋肉内薬物送達機器の製造コスト構成分析 ・筋肉内薬物送達機器の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・筋肉内薬物送達機器の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・筋肉内薬物送達機器のセグメント分析（種類別） （分子構造、ポリマー、ゲル、その他）...The global Intramuscular Drug Delivery Equipment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Intramuscular Drug Delivery Equipment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intramuscular Drug Delivery Equipment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Intramuscular Drug Delivery Equipment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆